Stock Earnings

Question 1

ACADIA Pharmaceuticals Incの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、ACADIA Pharmaceuticals Incの総資産は$1,187で、純profitは$226です。

Question 2

ACADの主要な財務比率は何ですか？

Accepted Answer

ACADIA Pharmaceuticals Incの流動比率は2.61、純利益率は23.61、1株当たり売上高は$5.75です。

Question 3

ACADIA Pharmaceuticals Incの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

ACADIA Pharmaceuticals Inc largest revenue segment is Innovative Medicines, at a revenue of 957,797,000 in the most earnings release.For geography, United States is the primary market for ACADIA Pharmaceuticals Inc, at a revenue of 957,797,000.

Question 4

ACADIA Pharmaceuticals Incは収益を上げていますか？

Accepted Answer

yes、最新の財務諸表によると、ACADIA Pharmaceuticals Incの純profitは$226です。

Question 5

ACADIA Pharmaceuticals Incに負債はありますか？

Accepted Answer

yes、ACADIA Pharmaceuticals Incの負債は454です。

Question 6

ACADIA Pharmaceuticals Incの発行済株式数は何株ですか？

Accepted Answer

ACADIA Pharmaceuticals Incの総発行済株式数は166.7株です。

Breakdown	TTM	12/31/2024	09/30/2024	12/31/2023	09/30/2023	12/31/2022
Revenue	1,047	957	0	726	-2	517
Revenue Growth (YoY)	122%	--	-100%	-72,700%	-100%	-51,800%
Cost of Revenue	84	81	0	41	--	10
Gross Profit	962	875	0	684	--	507
Selling, General & Admin	523	488	0	406	0	369
Research & Development	344	303	--	351	--	361
Operating Expenses	721	791	0	758	0	730
Other Non Operating Income (Expenses)	2	1	--	5	--	3
Pretax Income	273	258	-2	-51	-2	-213
Income Tax Expense	12	31	0	10	0	2
Net Income	261	226	-2	-61	-3	-216
Net Income Growth	243%	-11,400%	-97%	6,000%	-95%	21,500%
Shares Outstanding (Diluted)	170.65	166.36	187.33	163.81	7.5	161.7
Shares Change (YoY)	-16%	-11%	14%	2,738%	-95%	2,701%
EPS (Diluted)	1.53	1.36	-0.01	-0.37	-0.43	-1.34
EPS Growth	314%	-11,257%	-97%	86%	15%	568%
Free Cash Flow	216	157	-1	-23	0	-114
Free Cash Flow Per Share	1.26	0.94	0	-0.14	0	-0.7
Gross Margin	91.88%	91.43%	0%	94.21%	--	98.06%
Operating Margin	22.92%	8.77%	0%	-10.05%	100%	-43.13%
Profit Margin	24.92%	23.61%	0%	-8.4%	150%	-41.77%
Free Cash Flow Margin	20.63%	16.4%	0%	-3.16%	0%	-22.05%
EBITDA	264	99	--	-68	--	-221
EBITDA Margin	25.21%	10.34%	--	-9.36%	--	-42.74%
D&A For EBITDA	24	15	--	5	--	2
EBIT	240	84	-1	-73	-2	-223
EBIT Margin	22.92%	8.77%	0%	-10.05%	100%	-43.13%
Effective Tax Rate	4.39%	12.01%	0%	-19.6%	0%	-0.93%

ACADIA Pharmaceuticals Inc (ACAD) Price

ACAD Stock Price Chart

ACAD Income

Follow-Up Questions